1. Home
  2. VYGR vs HWBK Comparison

VYGR vs HWBK Comparison

Compare VYGR & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • HWBK
  • Stock Information
  • Founded
  • VYGR 2013
  • HWBK 1865
  • Country
  • VYGR United States
  • HWBK United States
  • Employees
  • VYGR N/A
  • HWBK N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • HWBK Major Banks
  • Sector
  • VYGR Health Care
  • HWBK Finance
  • Exchange
  • VYGR Nasdaq
  • HWBK Nasdaq
  • Market Cap
  • VYGR 235.4M
  • HWBK 242.4M
  • IPO Year
  • VYGR 2015
  • HWBK N/A
  • Fundamental
  • Price
  • VYGR $4.22
  • HWBK $32.95
  • Analyst Decision
  • VYGR Strong Buy
  • HWBK
  • Analyst Count
  • VYGR 9
  • HWBK 0
  • Target Price
  • VYGR $15.53
  • HWBK N/A
  • AVG Volume (30 Days)
  • VYGR 374.5K
  • HWBK 14.0K
  • Earning Date
  • VYGR 03-03-2025
  • HWBK 01-22-2025
  • Dividend Yield
  • VYGR N/A
  • HWBK 2.26%
  • EPS Growth
  • VYGR N/A
  • HWBK 1821.83
  • EPS
  • VYGR 0.47
  • HWBK 2.61
  • Revenue
  • VYGR $163,784,000.00
  • HWBK $71,882,000.00
  • Revenue This Year
  • VYGR N/A
  • HWBK N/A
  • Revenue Next Year
  • VYGR N/A
  • HWBK N/A
  • P/E Ratio
  • VYGR $9.13
  • HWBK $12.89
  • Revenue Growth
  • VYGR 3.40
  • HWBK 36.16
  • 52 Week Low
  • VYGR $4.00
  • HWBK $17.86
  • 52 Week High
  • VYGR $10.66
  • HWBK $35.95
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 29.98
  • HWBK 52.63
  • Support Level
  • VYGR $4.20
  • HWBK $32.94
  • Resistance Level
  • VYGR $4.60
  • HWBK $35.95
  • Average True Range (ATR)
  • VYGR 0.31
  • HWBK 1.21
  • MACD
  • VYGR -0.08
  • HWBK -0.04
  • Stochastic Oscillator
  • VYGR 12.36
  • HWBK 32.28

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

Share on Social Networks: